European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives

• Authors: VALENT Peter; HARTMANN Karin; BONADONNA Patrizia; SPERR Wolfgang; NIEDOSZYTKO Marek; KLUIN-NELEMANS Hanneke C; HERMINE Olivier; SOTLAR Karl; HOERMANN Gregor; NEDOSZYTKO Boguslaw; BROESBY-OLSEN Sigurd; ZANOTTI Roberta; LANGE Magdalena; DOUBEK Michael; BROCKOW Knut; ALVAREZ-TWOSE Ivan; VARKONYI Judit; YAVUZ Selim; NILSSON Gunnar; RADIA Deepti; GRATTAN Clive; SCHWAAB Juliana; GILLEN Theo; ELBERINK Hanneke N G Oude; HAEGGLUND Hans; SIEBENHAAR Frank; HADZIJUSUFOVIC Emir; SABATO Vito; MAYER Jiří; REITER Andreas; ORFAO Alberto; HORNY Hans-Peter; TRIGGIANI Massimo; AROCK Michel
• Year of publication: 2023
• Type: Article in Periodical
• Magazine / Source: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
• MU Faculty or unit: Faculty of Medicine
• web: https://www.sciencedirect.com/science/article/pii/S2213219823002258?via%3Dihub
• Doi: http://dx.doi.org/10.1016/j.jaip.2023.02.021
• Keywords: Mast cells; Mastocytosis; Mast cell activation dis-orders; MCAS; ECNM
• Description: In 2002, the European Competence Network on Mastocytosis (ECNM) was launched as a multidisciplinary collaborative initiative to increase the awareness and to improve diagnosis and management of patients with mast cell (MC) disorders. The ECNM consists of a net of specialized centers, expert physicians, and scientists who dedicate their work to MC diseases. One essential aim of the ECNM is to timely distribute all available information about the disease to patients, doctors, and scientists. In the past 20 years, the ECNM has expanded substantially and contributed successfully to the development of new diagnostic concepts, and to the classification, prognostication, and treatments of patients with mastocytosis and MC activation disorders. The ECNM also organized annual meetings and several working conferences, thereby supporting the license (http://creativecommons.org/licenses/by/4.0/). (J Al-Clin Immunol Pract 2023;11:1706-17)